Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Kidney Int. 2023 Jan 10;103(3):593–606. doi: 10.1016/j.kint.2023.01.001

Figure 2.

Figure 2.

Mass spectrometry data to support identification of a putative antigen in MN, using VASN as an example. A) Scaffold exclusivity plot demonstrating VASN peptides show significantly increased normalized exclusive intensity in the VASN index case compared to other MN samples; B) Protein heat map demonstrating VASN was highly enriched in the index case compared to other MN samples; C) Sequence coverage for VASN (unique peptides highlighted in yellow).